BIOMAT Database Logo BIOMAT Database Logo

Comparison of one week of oral terbinafine (250 mg/day) with four weeks of treatment with clotrimazole 1% cream in interdigital tinea pedis. 1998

R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
Department of Dermatology, Royal Prince Alfred Hospital, NSW, Australia.

Treatment of interdigital tinea pedis often involves long-term therapy with topically applied preparations. Effective oral preparations, such as the allylamine terbinafine (Lamisil), taken over a shorter period, could provide a useful therapeutic alternative. A total of 269 patients from five centres with clinically diagnosed interdigital tinea pedis were entered into this double-blind, randomized, double-dummy, parallel-group study comparing oral terbinafine 250 mg once daily for 1 week with 1% clotrimazole (Canesten) cream applied twice daily for 4 weeks. Of these, 137 patients were evaluable for efficacy (confirmed dermatophyte infection by microscopy and culture): 63 terbinafine and 74 clotrimazole. At week 4, the mycological cure rates (negative culture at week 1 and negative results on microscopy and culture at week 4 onwards) were very similar (71% for clotrimazole and 72% for terbinafine). There was a faster response rate in the terbinafine group with respect to signs and symptoms at week 1. Both treatments were equally well tolerated; adverse events occurred equally in the two groups. In conclusion, oral terbinafine in a single daily dose of 250 mg for 1 week is as effective and as well tolerated as 1% clotrimazole cream applied twice daily for 4 weeks in the treatment of interdigital tinea pedis.

UI MeSH Term Description Entries
D009281 Naphthalenes Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics.
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003022 Clotrimazole An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal CELL MEMBRANES. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. Bay b 5097,Canesten,FB b 5097,Kanesten,Klotrimazole,Lotrimin,Mycelex
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004821 Epidermophyton A fungal genus which grows in the epidermis and is the cause of TINEA. Epidermophytons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077291 Terbinafine A naphthalene derivative that inhibits fungal SQUALENE EPOXIDASE and is used to treat DERMATOMYCOSES of the skin and nails. (E)-N-(6,6-Dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride,DA 5505,Lamisil,SF 86-327,SF-86-327,TDT-067,Terbinafine Hydrochloride,Terbinafine, (Z)-,Terbinafine, (Z)-isomer,SF 86 327,SF 86327,SF86327,TDT 067,TDT067

Related Publications

R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
A comparison of terbinafine (Lamisil) 1% cream given for one week with clotrimazole (Canesten) 1% cream given for four weeks, in the treatment of tinea pedis.
April 1994, The British journal of dermatology,
R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
[One-week application of terbinafine cream compared with four-week application in treatment of Tinea pedis].
January 2001, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology,
R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study.
April 1994, The British journal of dermatology,
R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
Treatment outcome and relapse with short-term oral terbinafine (250 mg/day) in tinea pedis.
January 2005, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology,
R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar-type tinea pedis.
April 1995, The British journal of dermatology,
R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
Topical terbinafine and clotrimazole in interdigital tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.
April 1993, Journal of the American Academy of Dermatology,
R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
[Seven days of intermittent terbinafine 250 mg treatment in Tinea pedis].
January 2002, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology,
R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
Comparison of terbinafine and clotrimazole in treating tinea pedis.
September 1993, BMJ (Clinical research ed.),
R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole.
February 1995, Journal of the American Academy of Dermatology,
R S Barnetson, and J Marley, and M Bullen, and S Brookman, and P Cowen, and D Ellis, and T Williams
One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group.
August 2001, Medical mycology,
Copied contents to your clipboard!